Desordenes sexuales y del sueño en hombres con artritis reumatoide – la actividad alta de la enfermedad y la discapacidad funcional son factores asociados

12 Septiembre, 2024
03 Marzo, 2025
17 Marzo, 2025
Citar como:
Citar como Santos-Moreno P, Rodriguez-Vargas G, Villarreal L, Buitagro D. Desordenes sexuales y del sueño en hombres con artritis reumatoide – la actividad alta de la enfermedad y la discapacidad funcional son factores asociados. Global Rheumatology. Vol 6/ Ene - Jun [2025]. Available from: https://doi.org/10.46856/grp.10.e198 

Lecturas 253Lecturas

Licencia

Este es un artículo de acceso abierto, distribuido bajo los términos de Creative Commons Attribution (CC .BY. NC-4). Esta permitido copiar y redistribuir el material en cualquier medio o formato. Remezclar, transformar y construir a partir del material . Usted debe dar crédito de manera adecuada, brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante. Usted no puede hacer uso del material con propósitos comerciales.

Sexual and sleep disorders in male patients with rheumatoid arthritis - High disease activity and functional disability are associated factors.

Resumen

Resumen /Abstract

Resumen en Español

Introducción: La artritis reumatoide (AR) es una enfermedad crónica de origen autoinmune y se presenta con mayor frecuencia entre los 40 y 60 años. La AR se asocia a comorbilidades como trastornos sexuales y trastornos del sueño que
afectan la calidad de vida del paciente.

Objetivo: Evaluar los factores de riesgo asociados y la prevalencia de los trastornos sexuales y del sueño en pacientes varones con AR.

Métodos: Estudio de corte transversal analítico. Se incluyeron 273 varones diagnosticados con AR, que fueron evaluados por psicología y se diagnosticaron con el Manual Diagnóstico y Estadístico de los Trastornos Mentales (DSM-V).

Resultados: La prevalencia de trastornos sexuales fue del 37,7% (103/273) con una mediana de edad de 61 años (Interquartile range [IQR]: 55-65) (p = 0,058). Con respecto a los trastornos del sueño, la prevalencia fue del 30,7% (84/273) con una mediana de edad de 62 años (IQR: 58-67) (p<0,001). Se observó asociación entre la presencia de comorbilidades: diabetes, hipertensión (20,3% vs. 10,6%, p = 0,025), y las comorbilidades autoinmunes (78,6% vs. 59,4%, p = 0,001) con los trastornos sexuales.

Conclusión: Los trastornos sexuales y del sueño están presentes en un tercio de los pacientes varones con AR. Se encontró asociación entre la edad, y la presencia de comorbilidades autoinmunes con los trastornos sexuales y del sueño. El manejo de los trastornos sexuales y del sueño debe ser parte de un esquema de manejo integral en la AR.

Palabras clave (MeSH):  Artritis reumatoide, Disfunción sexual, Trastornos del sueño, Calidad de vida, Trastornos psicológicos.

Resumen en Inglés

Introduction: Rheumatoid arthritis (RA) is a chronic disease of autoimmune origin and occurs most frequently between the ages of 40 and 60. RA is associated with comorbidities such as sexual disorders and sleep disorders that affect the patient's quality of life.

Objective: To evaluate the associated risk factors and prevalence of sexual and sleep disorders in male patients with RA.

Methods: Analytical cross-sectional study. 273 men diagnosed with RA were included, who were evaluated by psychology and diagnosed with the Diagnostic and Statistical Manual of Mental Disorders (DSM-V).

Results: The prevalence of sexual disorders was 37.7% (103/273) with a median age of 61 years (Interquartile range [IQR]: 55-65) (p = 0.058). Regarding sleep disorders, a prevalence of 30.7% (84/273) was observed with a median age of 62 years (IQR: 58-67) (p<0.001). An association was observed between the presence of comorbidities such as diabetes, hypertension (20.3% vs. 10.6%, p = 0.025), autoimmune comorbidities (78.6% vs. 59.4%, p = 0.001) with sexual disorders.

Conclusion: Sexual and sleep disorders are present in a third of male patients with RA. An association was found between age and the presence of autoimmune comorbidities with sexual and sleep disorders.The management of sexual and sleep disorders should be part of a comprehensive management scheme in RA.

Keywords (MeSH):  Rheumatoid arthritis, Sexual dysfunction, Sleep disorders, Quality of life, Psychological disorders.

Resumen en Portugués

Introdução: A artrite reumatoide (AR) é uma doença crônica de origem autoimune e ocorre com maior frequência entre 40 e 60 anos. A AR está associada a comorbidades como distúrbios sexuais e distúrbios do sono que afetam a qualidade de vida do paciente.

Objetivo: Avaliar os fatores de risco associados e a prevalência de distúrbios sexuais e do sono em pacientes do sexo masculino com AR.

Métodos: Estudo transversal analítico. Foram incluídos 273 homens com diagnóstico de AR, avaliados pela psicologia e diagnosticados com o Manual Diagnóstico e Estatístico de Transtornos Mentais (DSM-V).

Resultados: A prevalência de distúrbios sexuais foi de 37,7% (103/273) com mediana de idade de 61 anos (intervalo interquartil [IIQ]: 55-65) (p = 0,058). Em relação aos distúrbios do sono, observou-se uma prevalência de 30,7% (84/273) com mediana de idade de 62 anos (IIQ: 58-67) (p<0,001). Foi observada associação entre a presença de comorbidades como diabetes, hipertensão (20,3% vs. 10,6%, p = 0,025), comorbidades autoimunes (78,6% vs. 59,4%, p = 0,001) com distúrbios sexuais.

Conclusão: A prevalência de distúrbios sexuais e do sono está presente em um terço dos pacientes. Foi encontrada associação entre idade e presença de comorbidades autoimunes com distúrbios sexuais e do sono. O manejo dos distúrbios sexuais e do sono deve fazer parte de um esquema abrangente de manejo na AR.

Palavras-chave (MeSH):  Artrite reumatóide, Disfunção sexual, Distúrbios do sono, Qualidade de vida, Distúrbios psicológicos.

Introducción

Introduction

Rheumatoid arthritis (RA) is a chronic disease of autoimmune origin, which affects the musculoskeletal system and in most of cases, involves both psycho-affective and physical aspects [1]. The prevalence of RA ranges between 1 to 1.5% in the world population. These values are similar for Latin America (0.9% to 1.5%) and occur most frequently between 40 and 60 years of age [2-4]. RA is often associated with comorbidities such as sexual and sleep disorders that can vary between 31 to 70% [5, 6], and which clearly affect the patient’s quality of life. RA is more frequent in women than in men with a ratio of 3 to 1, and specifically for men prevalence range between 0.2 and 0.5% [7]. The patients’ well-being perception is associated with disability as well as pain management, and the ability to communicate it .

RA affects sexual function, reproductive ability, and causes secondary symptoms that affect sleep quality, mood changes and social interaction. The prevalence of sexual dysfunction and sleep disorders in patients with RA is notably high. Sexual dysfunction is a significant concern. Studies showing that 67% of RA patients experience sexual dysfunction, particularly difficulties in sex drive, arousal, and orgasm(8). In female patients, sexual dysfunction prevalence is 47.8%, compared to 14.2% in healthy controls, highlighting the significant burden of this condition in RA (9). A meta-analysis reports a pooled prevalence of female sexual disorders (FSD) in RA patients of 49.1%, with depression and menopause being major risk factors (10).

For men, acknowledging these changes can be difficult due to societal expectations surrounding masculinity [6, 11]. In this manner, the patient-physician relationship becomes the only bridge to find-out about these types of conditions, where patients expect to find spaces of confidence to refer to the "private" or "unimportant" symptoms that affect their quality of life [12-14]. In men population, the relationship between sexual alterations and the presence of RA is known [15], which reaches up to 15% of prevalence. The study published by Guo G, et al. reported that psychological alterations have been under-recorded in male patients with RA, due to the lack of diagnosis by health professionals. However, they found a prevalence of 78.6% sleep disorders in male patients with RA [16, 17].

Sexual dysfunction and sleep disorders significantly impact the quality of life (QoL) in patients with RA, as evidenced by several studies. Tanski found that patients with reduced QoL and pain limiting social life, had a higher risk of sexual dysfunction, highlighting the need for comprehensive management of these symptoms to improve overall well-being (18). Poor sleep quality is linked to decreased physical and mental health-related QoL, as demonstrated by studies using the Pittsburgh Sleep Quality Index (PSQI) and the Short Form Health Survey (SF-36) (19,20).

There are theories that explain sleep disorders with immunological mechanisms, as well as the use of biological drugs. In the same way, the use of medications such as sulfasalazine and leflunomide have reported a relationship with sleep disorders, as well as endothelial damage, hence vascular and erectile dysfunction [20, 21, 22]. The description of these pathologies has been done mainly in women. On the other hand, for men the evidence regarding these disorders is scarce [7]. According to the above, the objective of this study was to know the frequency and the associated risk factors of sexual and sleep disorders in a population of male patients with a diagnosis of RA attending a specialized center.

Material y Métodos

Methods

Design

An observational analytical cross-sectional study was carried-out in a specialized center for the treatment of autoimmune pathologies in Bogotá, Colombia.

Population

Inclusion criteria: we included all male patients over 18 years, with an RA diagnosis considering the ACR/EULAR 2010 Rheumatoid Arthritis Classification Criteria [23]. Patients were followed-up and treated by a rheumatologist who carried out a clinical examination (tender and swollen joint count, DAS28, HAQ, etc), and a whole blood test for: ESR, creatinine, alanine aminotraferase, alkaline phosphatase, rheumatoid factor, and anticitrullinated antibodies. Patients were also evaluated by a comprehensive care program for RA patients which includes a multidisciplinary evaluation by different health care professionals (rheumatologist, psychologist, physiatrist, physical therapist, occupational therapist, nutritionist and pharmaceutical chemist). We excluded patients without information about disease activity (DAS28) and functionality (HAQ) . Data Collection: Data were sourced from the clinical records system of the rheumatology center [24]. To guarantee the patients' confidentiality, the information analyzed did not include variables that could identify the patient. The information included in this study was collected between July of 2011 to July 2021.

Variables

The presence of sexual and sleep disorders was established as a dependent variable. All other variables were considered as independent variables or related factors: DAS28 (Disease Activity Score) to classify the disease activity, which was categorized as non activity: remission (<2.6), low disease activity (>=2.6 - 3.2<), moderate disease activity (>=3.2 - 5.1<) [25] high disease activity (> = 5.1) and functionality/functional capacity with the HAQ (Health Assessment Questionnaire) scale, categorized into: no disability (<0.1), mild disability (>=0.1-1<), moderate disability (>=1-2<) and severe disability (>= 2) [26, 27] . The treatment was classified in conventional DMARDs (csDMARDs) and treatment with biological DMARDs (bDMARDs). For the diagnosis of sexual disorders and sleep disorders (psychological disorders), patients were evaluated by a psychologist with experience in RA, who based their diagnosis in the Diagnostic and Statistical Manual of Mental Illnesses (DSM V), which is a comprehensive classification system for mental disorders, developed by the American Psychiatric Association. It serves as a critical tool for clinicians and researchers providing standardized criteria for the diagnosis of mental disorders [28]. Although other questionnaires could have been used to provide additional insights, these were not included due to time constraints.

In the same way, the clinical evaluation by health professionals, who are part of the comprehensive care program, includes an interdisciplinary board that allows evaluating the diagnosis of sexual and sleep disorders, suggested by the clinical psychologist.

Statistical analysis

A descriptive analysis of the data was made using absolute and relative frequencies for the categorical variables, and measures of central tendency and dispersion for continuous variables. We assessed the relationship between variables comparing the first assessment versus comparing the control at the time of diagnosis; a p-value less than 0.05 was considered for the hypothesis test. Data was analyzed in STATA 12.

Ethical considerations

All the patients gave the written informed consent previous explanation, for analyzes of the data. This study took in to account the international regulation for research with human beings and considered the Colombian research regulation (Resolution 8430-1993, “classifying: minimum risk”). It was presented to and approved by the BIOMAB research committee in ordinary session on April 4, 2019, registered in folder 25.

Resultados

Results

A total of 273 male patients with a diagnosis of RA were analyzed. The median age was 60 (Interquartile range (IQR): 54-64). The majority were married (64.1%), while 11.7% were single, 19% divorced, and 5.1% widowed. Regarding employment status 143 patients (52.4%) were actively working, 65 (23.8%) were dedicated to recreation/sports, and 62 (22.7%) do not have special activity; of the last ones, 30 patients (10.7%) were engaged in household activities (Table 1).

The frequency of sexual disorders was 37.7% (103/273) with a median age of 61 years (IQR: 55-65). Out of all the patients with sexual disorders, the most frequent one was premature ejaculation with 34.9% (Figure 1).

When analyzing factors associated with sexual disorders, patients with these conditions were significantly older (p = 0.049) and were more frequently single (25.2% vs. 15.3%, p = 0.001). Additionally, smoking (21.3% vs. 11.2%, p = 0.022), diabetes-hypertension (20.3% vs. 10.6%, p = 0.025), and the presence of autoimmune comorbidities (78.6% vs. 59.4%, p = 0.001) were significantly associated with sexual dysfunction (Table 2).

When we assessed the presence of comorbidities, 60 patients (21.9%) had other autoimmune diseases different of RA, non-autoimmune diseases in 122 patients (44.6%), and 44 subjects (16.1%) had a coexistence of autoimmune and non-autoimmune diseases. The remaining 91 cases (33.3%) did not report comorbidities.

With regards to the characteristics of RA in the population studied, the disease activity showed that 89 (32.6%) were in remission, 50 (18.3%) in low disease activity, 93 (34.1%) in moderate disease activity, and 41 (15%) in high disease activity. In relation to pharmacological therapy, 68 (24.9%) were being treated with bDMARDs and 205 (75.1%) with csDMARDs (Table 2).

We compared the clinical measurements related to RA, the disease activity (DAS28) at the time of the initial evaluation, presenting a median of DAS28 of 3.17 (IQR: 2.38-4.49). In the case of functional capacity (HAQ) the median in the initial assessment was 0.25 (IQR: 0.12-0.75). This analysis showed a median DAS28 of 3.55 in the cases of patients with sexual disorders (IQR: 2.63-4.73) and without sexual disorders a median of 3.02 (IQR. 2.24-4.29) (p = 0.004), while in the case of functionality, the HAQ in patients with sexual disorders showed a median of 0.375 (IQR: 0.125-0.1125) and in patients without sexual disorders a median of 0.125 (IQR: 0.12-0.5) (p = 0.001).

The frequency of sleep disorders was 30.7% (84/273). Mean age of participants with sleep disorders was 62 years (IQR: 58-67). The most common sleep disturbances are described in Figure 2 with insomnia as the most prevalent sleep disorder (77.3%). In the same way, as in sexual disorders, the associations between sleep disorders and the socio-demographic and clinical variables were explored, and it was found that age and the presence of comorbidities were associated with sleep disorders. Like sexual disorders, patients with sleep disorders were significantly older (p = 0.001) and more frequently unemployed (35.7% vs. 49.7%, p = 0.032).

Additionally, the presence of autoimmune comorbidities was strongly associated with sleep disorders (84.5% vs. 58.7%, p = 0.001) (Table 2). The DAS28 and HAQ of the first evaluation were also compared according to the presence of sleep disorders, which are shown below: for the case of DAS28, patients with sleep disorders presented a median of 3.79 (IQR: 3.08-5.42), while those without a sleep disorder had a median of 2.94 (IQR: 2.24-4.17) (p = < 0.001). Regarding functional capacity, the HAQ in the group of sleep disorders a median of 0.37 (IQR: 0.122-1) was observed, compared with a median of 0.25 (0.12-0.625) in the group that had no sleep disorder (p = 0.008).

Discusión y Conclusión

Discussion

The association between RA and sexual and sleep disorders has been understudied in men, despite its impact on quality of life, and the comprehensive management of this chronic disease. This study, conducted at a specialized rheumatology center in Bogotá, Colombia, focuses on a population underrepresented in the scientific literature, highlighting clinical and sociodemographic factors associated with these conditions. Compared to other populations, the Colombian male RA cohort examined in this study reflects a distinct set of challenges highlighting the importance of considering differences in characteristics in the management of these disorders.

This study discovered that sexual disorders were found in a third of patients, most commonly premature ejaculation, and were associated with higher disease activity (median DAS28 of 3.55) and worse functional capacity (median HAQ of 0.375). These findings are in line with previous studies, but the prevalence rate observed here is lower than the 50-60% typically reported in the literature for male RA patients (29). Sleep disorders affected a third of patients, with similar associations to disease activity (median DAS28 of 3.79) and functional impairment (median HAQ of 0.37). These findings highlight the significant frequency of sexual and sleep disorders in RA male patients and underscore the need for an improved communication and a comprehensive management that includes attention to these aspects of patient health.

The relationship between the symptoms of RA and its impact on psychological aspects is clear, which implies an alteration in quality of life and social welfare (18). For this reason, identification of pathologies such as sexual and sleep disorders have become part of the comprehensive management when a patient with RA is approached, forcing treatment centers to structure interdisciplinary care programs, with the goal of attaining a global improvement for the patients and their disease. This is why these interventions have shown effectiveness independently of gender. We clarify that the analysis carried out in this study re-affirms the need for a comprehensive approach for all patients with RA, despite the fact that there is no difference between men and women, the male population represents a considerably smaller proportion and, therefore, the probability of consultation decreases. [11, 13]. According to the above, the approach begins with an adequate relationship between the patient and the health professional, which requires that spaces of confidence be given so that the patient can communicate this type of symptoms, or making experts in psychology available within the interdisciplinary team, under the cultural context, where the macho society hinders the communication of the male patient with the treating doctor [30]. This need is reflected in studies that report that only 36% of patientsmentioned other pathologies concomitant to their baseline RA and the remaining 64% did not trust their doctor, or the consultation was too short to talk about it [30].

Additionally, between 31% and 56% believe that these types of diseases are not relevant and are not associated with RA, as well as the presence of mental illnesses such as depression and anxiety that have been related to RA [31-34]. Due to the above, education, coping and acceptance of the disease, become tools to improve this communication and thus guarantee a global treatment for RA and its comorbidities.

Our results, report a lower frequency of sexual disorders, but it could be explained by the patient's lack of trust in the health professionals, given that the patients included in this study entered the comprehensive care program of the RA reference center. This argument is in agreement with those described in the literature, as early identification usually occurs in the second or third consultation, once the doctor-patient relationship has been established. [35]. Van Berlo points out that men tend to prioritize their physical appearance and body functionality, while women place greater emphasis on emotional, social, and cultural aspects. This contrast reflects how social expectations influence the perception of conditions associated with RA in both genders [37].

According to what was analyzed in this study, the  relationship between disease activity and patent functionality is clear, with the presence of sexual disorders (p = 0.004), because the patients without sexual alterations had better clinical measurements in the first evaluation. This reinforces the notion that disease activity, particularly its impact on functionality, is a key factor contributing to sexual dysfunction in male RA patients. This association is understood by the pathophysiology of RA, which involves stiffness, acute and chronic pain, and alteration in the hormonal mechanisms that are related to immunomodulation; this could also explain the association between autoimmune comorbidities and the presence of sexual disorders (p = 0.001) and sleep disorders (p <0.001). With regards to pain, joint compromise, specifically in the hip, knee and upper limbs, hinder activities related to intercourse, more in men than in women, which affects sexual activity, sexual desire, and masturbation [19, 29, 36]. This distinction between men and women in the way that joint compromise impacts sexual activity underscores the need for a gender-specific approach when addressing sexual dysfunction in RA patients.

Another relevant aspect that was associated with exual disorders was tobacco consumption, autoimmune comorbidities, depression-anxiety, and diabetes-hypertension, which are related to erectile dysfunction and which are explained by direct damage to the endothelium, alterations in the smooth muscle, and its direct consequence in vascular insufficiency [15, 19]. The complex interplay between these factors and sexual dysfunction highlights the need for an integrated approach to RA treatment that considers not only the RA symptoms but also the comorbidities that may exacerbate sexual health issues.

However, in this study no association was found between sexual disorders and sleep disorders, with depression and anxiety, despite the fact that some authors report significant relationships [6]. This relationship can be explained, because if there is a basic mental pathology, the other emotional components are affected, within these the sexual ones. In the same way, it is well known that this type of pathology is directly related to sleep disorders, either by the pathology per se or by concomitant pharmacological treatment. It is important to note that this relationship is also associated with age, as the older patients are more likely to have atherosclerotic vascular alterations, which reaffirms what was found in this study [36]. As such, age should be considered a significant factor when evaluating the risk of sexual dysfunction and sleep disorders in RA patients.

When compared with women's sexual disorders, the difference in symptoms is clear, since what most often affects men is premature ejaculation and orgasmic decrease, whereas in women it is dyspareunia and vaginal dryness. These problems could be improved if there is a treatment for RA and a psychological intervention with both the patient and his partner [38, 39]. Finally, no significant differences were found with the use of DMARDs (p = 0.85), and sexual dysfunction, although the literature suggests it, specifically with the use of methotrexate and leflunomide. This finding contrasts with some literature reports, but it could reflect differences in the study populations or treatment regimens. Once RA is diagnosed and drug treatment is started, with improving the disease activity, is expected a direct impact on the psychological and sexual aspects of the patient [6].

With respect to sleep disorders, there is an explanation regarding a pathological cycle that begins with the presence of chronic pain and ends with the alteration of proinflammatory mechanisms. Abad describes that sleep disturbances elevate TNF and IL- 6 which are present in autoimmune processes, and in patients with RA worsen and increase the activity of the disease, and that by not being controlled generate chronic pain, which in turn cause sleep alterations such as sleep quality, non-restful sleep, and multiple awakenings [18, 39]. Another pathology described in this type of disorders is obstructive sleep apnea/hypopnea syndrome (OSAHS), which is more frequent in men due to their muscle structure and is associated with the reduction of the mandibular opening due to joint involvement (temporomandibular), and in some cases arthritis in the cricoarytenoid joint is present, generating hypoxia and sleep deprivation, being more frequent in men than in women [18, 35].

Finally, in this study, it was possible to establish the association between age (p = < with sexual and sleep disorders, and work activity (p = 0.003) with sleep disorder, which could be explained as men are more active at work which improves their physical activity and therefore chronic pain [40]. Engaging in work and physical activity may help mitigate chronic pain and improve overall health. As such, RA treatment should incorporate lifestyle modifications alongside pharmacological interventions to optimize patient outcomes [40].

New pharmacological developments have allowed for better control of the disease. However, the costs and adverse effects that have not yet been described in detail require pharmacovigilance monitoring by the health professional. This must go under an integral structure where cultural and gender characteristics are considered. According to this,comprehensive treatment centers play a relevant role in RA management and personalized treatment, where “objectives by target” has become the path that shows better results. In this same way, once the patient is approached comprehensively, there can be comprehensive educational strategies as well as recreational activities that could improve quality of life, and that will directly impact the patient's disease activity and functionality.

It is important to highlight the relevance of generating spaces adapted to each patient, where the personal and cultural context play a significant role when comprehensively addressing the exclusive pathologies of men, forcing the construction and adaptation of strategies, to actively search for sexual and sleep disorders, and initiate timely treatment. All these actions would decrease the times of diagnosis and start of treatment, directly affecting the prognosis, both of the RA and of comorbidities [9, 41].

This study has important limitations, considering that specific scales were not used, only the DSM-V for the diagnosis of sexual and sleep disorders. However, the experience acquired, and the support of the interdisciplinary group, especially the psychological evaluation, bring us closer to the reality of these patients. Another weakness of the study is that, despite being an analytical cross-sectional study, it cannot establish a direct causal association due to its design. However, it does allow for the examination of variables of interest that may influence the outcomes described. Among the main biases present is selection bias, as the chosen population is highly specific to a reference center for rheumatoid arthritis, and the selection was made based on convenience.

To address these issues, future studies could incorporate more objective measures and consider broader, more diverse populations. Additionally, it would be valuable to routinely assess sexual function and sleep disorders during consultations for male patients with rheumatoid arthritis, to improve early detection and intervention, thereby enhancing the quality of life for these patients.

Conclusions

Our study reports a frequency of sexual and sleep disorders in one third of male patients with RA, which is likely to the descriptions reported in similar studies. We found that age, the presence of non-autoimmune and autoimmune comorbidities, disease activity, and the functionality of the patient was associated with sexual and sleep disorders. Finally, communication skills between patients and health professionals considering the characteristics of each patient and their social and cultural context, needs improvement. This strategy should be part of a comprehensive management scheme that involves different health specialties that offer not only a pharmacological treatment but a treatment that also prevents comorbidities. To improve clinical practice, it is crucial to integrate routine evaluations of sexual health and sleep quality into patient assessments for those with RA. This approach could lead to better management and outcomes for these patients, helping to identify and address issues that may impact their quality of life.helping to identify and address issues that may impact their quality of life.

Conflicto de intereses

The authors declare that there are no conflicts of interest regarding this manuscript.

Financiación

.

Referencias

[1] Zyrianova Y, B.D. Kelly, J. Sheehan, C. McCarthy, T.G. Dinan, The psychological impact of arthritis: the effects of illness perception and coping, Ir J Med Sci 180(1) (2011) 203-10.

[2] Díaz-Rojas J, Dávila F, Quintana G, Aristizábal F, Brown P, Prevalencia de artritis reumatoide en Colombia: una aproximación basada en la carga de la enfermedad durante el año 2005, Revista Colombiana de Reumatología 23(1) (2016) 11-16.

[3] Gabriel S, Michaud K, Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases, Arthritis Res Ther 11(3) (2009) 229.

[4] I. Pelaez-Ballestas, L.H. Sanin, J. Moreno-Montoya, J. Alvarez-Nemegyei, R. Burgos- Vargas, M. Garza-Elizondo, J. Rodriguez-Amado, M.V. Goycochea-Robles, M. Madariaga, J. Zamudio, N. Santana, M.H. Cardiel, Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology, J Rheumatol Suppl 86 (2011) 3-8.

[5] Tristano AG, Impact of rheumatoid arthritis on sexual function, World J Orthop 5(2) (2014) 107-11.

[6] Perez-Garcia LF, B. te Winkel, J.P. Carrizales, W. Bramer, S. Vorstenbosch, E. van Puijenbroek, J.M.W. Hazes, R.J.E.M. Dolhain, Sexual function and reproduction can be impaired in men with rheumatic diseases: A systematic review, Seminars in Arthritis and Rheumatism (2020).

[7] Carmona L, Epidemiología de la artritis reumatoide, Revista Española de Reumatología 29(3) (2002) 86-90.

[8] Serna-Peña G, Flores-Gutierrez DP, Vega-Sevilla LF, et al. Sexual dysfunction and self- perceived  sexual  health  in  patients  with  rheumatoid  arthritis  and  systemic  lupus erythematosus: Results from a cross-sectional survey. Rheumatol Int. 2024;44(10):2139- 2145. doi: 10.1007/s00296-024-05648-8.}

[9] Puchner R, Sautner J, Gruber J, et al. High burden of sexual dysfunction in female patients with rheumatoid arthritis: Results of a cross-sectional study. J Rheumatol. 2019;46(1):19-26.                           doi:                                    10.3899/jrheum.171287.

[10]. Huang J, Guo C, Sun J, Hua R, Fan Y. Prevalence and risk factors of sexual dysfunction in female participants with rheumatoid arthritis: A systematic review and meta- analysis. J Sex Med. 2024;21(11):1037-1046. doi: 10.1093/jsxmed/qdae114.

[11] Perdriger A, C. Solano, L. Gossec, Why should rheumatologists evaluate the impact of rheumatoid arthritis on sexuality?, Joint Bone Spine, France, 2010, pp. 493-5.

[12] Santos-Moreno P, Villarreal L, Ballesteros G, Bello J, Castillo E, Giraldo R, Gomez D, Aza A, Lopez A, Cardozo A, P. N, Castro CA, Buitrago-Garcia D, Presence of psychological, sexual and sleep disorders in patients with rheumatoid arthritis., Annals of the Rheumatic Diseases. 75(2) (2016).

[13] Santos-Moreno P, O. Castañeda, B. Garro, D. Flores, G. Sánchez, C. Castro, From the model of integral attention to the creation of centers of excellence in rheumatoid arthritis, Clin Rheumatol 34 Suppl 1 (2015) S71-7.

[14]     Organización     Mundial     de    la     Salud     -     OMS,     Health     Sexual.,     2016. http://www.who.int/topics/sexual_health/en/. 2018).

[15] Keller J, H.C. Lin, A population-based study on the association between rheumatoid arthritis and erectile dysfunction, Ann Rheum Dis, England, 2012, pp. 1102-3.

[16] Guo G, T. Fu, R. Yin, L. Zhang, Q. Zhang, Y. Xia, L. Li, Z. Gu, Sleep quality in Chinese patients with rheumatoid arthritis: contributing factors and effects on health-related quality of life, Health Qual Life Outcomes 14(1) (2016) 151.

[17] Cohen JD, M. Dougados, P. Goupille, A. Cantagrel, O. Meyer, J. Sibilia, J.P. Daures, B. Combe, Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritis, J Rheumatol 33(10) (2006) 1936-41.

[18]. Tański W, Dudek K, Tomasiewicz A, Świątoniowska-Lonc N. Sexual dysfunction and quality of life in patients with rheumatoid arthritis. Int J Environ Res Public Health. 2022;19(5):3088.                                     doi:                                     10.3390/ijerph19053088

[19]. Tański W, Świątoniowska-Lonc N, Tomasiewicz A, Dudek K, Jankowska-Polańska B. The impact of sleep disorders on the daily activity and quality of life in rheumatoid arthritis patients: A systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2022;26(9):3212-3229.                          doi:                         10.26355/eurrev_202205_28740.

[20].Kim SH, Kim H, Kim S, et al. Sleep quality independently affects health-related quality of life and cognitive function in Korean female patients with rheumatoid arthritis: case-control study. J Korean Med Sci. 2018;33(35):e216. doi: 10.3346/jkms.2018.33.e216.

[21] Abad VC, P.S. Sarinas, C. Guilleminault, Sleep and rheumatologic disorders, Sleep Med Rev 12(3) (2008) 211-28.

[22] Gaber W, A. Moghazy, M. Niazy, H.K. Salem, Risk factors for sexual dysfunction in Egyptian patients with rheumatoid arthritis and its relation to disease activity, The Egyptian Rheumatologist 39(3) (2017) 135-138.

[23] Aletaha D, T. Neogi, A.J. Silman, J. Funovits, D.T. Felson, C.O. Bingham, 3rd, N.S. Birnbaum, G.R. Burmester, V.P. Bykerk, M.D. Cohen, B. Combe, K.H. Costenbader, M. Dougados, P. Emery, G. Ferraccioli, J.M. Hazes, K. Hobbs, T.W. Huizinga, A. Kavanaugh, J. Kay, T.K. Kvien, T. Laing, P. Mease, H.A. Menard, L.W. Moreland, R.L. Naden, T. Pincus, J.S. Smolen, E. Stanislawska-Biernat, D. Symmons, P.P. Tak, K.S. Upchurch, J. Vencovsky, F. Wolfe, G. Hawker, 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum 62(9) (2010) 2569-81.

[24] Ministerio de Salud y Protección Social, Fondo colombiano para enfermedades de alto costo            -            Cuenta            de            alto            costo            (Artritis).            2018. https://cuentadealtocosto.org/site/index.php/patologias/9-patologias/97-artritis01/?template=cuentadealtocostocontenido. 2018).

[25] Aletaha D, M.M. Ward, K.P. Machold, V.P. Nell, T. Stamm, J.S. Smolen, Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states, Arthritis Rheum 52(9) (2005) 2625-36.

[26] Bruce B, J.F. Fries, The Health Assessment Questionnaire (HAQ), Clin Exp Rheumatol 23(5 Suppl 39) (2005) S14-8.

[27] Fries JF, P. Spitz, R.G. Kraines, H.R. Holman, Measurement of patient outcome in arthritis, Arthritis Rheum 23(2) (1980) 137-45.

[28] Spitzer RL, DSM-IV-TR Casebook: A Learning Companion to the Diagnostic and Statistical  Manual  of  Mental  Disorders,  Fourth  Edition,  Text  Revision,  American Psychiatric Pub.2002.

[29] Carrillo González G, B. Sánchez Herrera, L. Chaparro Díaz, Chronic disease and sexuality, Investigación y Educación en Enfermería 31 (2013) 295-304.

[30] Kobelt G, B. Texier-Richard, S. Mimoun, A.S. Woronoff, D.R. Bertholon, A. Perdriger, Y. Maugars, B. Combe, Rheumatoid arthritis and sexuality: a patient survey in France, BMC Musculoskelet Disord 13 (2012) 170.

[31] Ostlund G, M. Bjork, E. Valtersson, A. Sverker, Lived Experiences of Sex Life Difficulties  in  Men  and  Women  with  Early  RA  -  The  Swedish  TIRA  Project, Musculoskeletal Care 13(4) (2015) 248-57.

[32] Helland Y, H. Dagfinrud, T.K. Kvien, Perceived influence of health status on sexual activity in RA patients: associations with demographic and disease-related variables, Scand J Rheumatol 37(3) (2008) 194-9.

[33] Sariyildiz MA, I. Batmaz, M. Bozkurt, Y. Bez, M.G. Cetincakmak, L. Yazmalar, D. Ucar, T. Celepkolu, Sleep quality in rheumatoid arthritis: relationship between the disease severity, depression, functional status and the quality of life, J Clin Med Res 6(1) (2014) 44-52.

[34] Sariyildiz MA, I. Batmaz, B. Dilek, A. Inanir, Y. Bez, M. Tahtasiz, S. Em, R. Cevik, Relationship of the sexual functions with the clinical parameters, radiological scores and the quality of life in male patients with ankylosing spondylitis, Rheumatol Int 33(3) (2013) 623-9.

[35] Miedany Y, M. El Gaafary, N. El Aroussy, S. Youssef, I. Ahmed, Sexual dysfunction in rheumatoid arthritis patients: arthritis and beyond, Clin Rheumatol 31(4) (2012) 601-6.

[36] Vakil M, S. Park, A. Broder, The complex associations between obstructive sleep apnea and auto-immune disorders: A review, Med Hypotheses 110 (2018) 138-143.

[37] van Berlo VT, H.B. van de Wiel, E. Taal, J.J. Rasker, W.C. Weijmar Schultz, M.H. van Rijswijk, Sexual functioning of people with rheumatoid arthritis: a multicenter study, Clin Rheumatol 26(1) (2007) 30-8.

[38] Khnaba D, S. Rostom, R. Lahlou, R. Bahiri, R. Abouqal, N. Hajjaj-Hassouni, Sexual dysfunction and its determinants in Moroccan women with rheumatoid arthritis, Pan Afr Med J 24 (2016) 16.

[39] Cáliz Cáliz R, Enfermedades reumáticas y alteraciones del sueño, Vigilia-Sueño 17(2) (2005) 113-115.

[40] Josefsson KA, G. Gard, Sexual health in patients with rheumatoid arthritis: experiences, needs and communication with health care professionals, Musculoskeletal Care 10(2) (2012) 76-89.

[41] Santos-Moreno P, Villarreal L, Bello J, Palacio N, Castro CA, Buitrago-Garcia D, Sleep disorders in patients with rheumatoid arthritis and relationship with disease activity, Annals of the Rheumatic Diseases. 76(2) (2017) 538.

Figure 1. Description of sexual disorders

Figure 2. Description of sleep disorders

enviar Envía un artículo